04/22/2024 7:35 PM | Annexon (Subject) BB BIOTECH AG (Filed by)
| Form SC 13G | |
04/10/2024 6:17 PM | Annexon (Issuer) Carson William H. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2024 11:15 PM | Annexon (Filer)
| Form EFFECT | |
03/26/2024 4:01 PM | Annexon (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/26/2024 4:05 PM | Annexon (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
03/26/2024 3:05 PM | Annexon (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/26/2024 3:10 PM | Annexon (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
|
02/20/2024 2:12 PM | Annexon (Subject) Overdorf Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024 2:12 PM | Annexon (Subject) Lew Jennifer (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024 2:15 PM | Annexon (Subject) Yednock Ted (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024 7:46 PM | Annexon (Subject) Venrock Healthcare Capital Partners II, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024 6:56 PM | Annexon (Issuer) Love Douglas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 6:59 PM | Annexon (Issuer) Overdorf Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 6:52 PM | Annexon (Issuer) Yednock Ted (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 6:54 PM | Annexon (Issuer) Lew Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 2:45 PM | Annexon (Subject) Fairmount Funds Management LLC (Filed by)
| Form SC 13G/A | |
02/14/2024 11:43 AM | Annexon (Subject) EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/14/2024 9:26 AM | Annexon (Subject) BIOTECHNOLOGY VALUE FUND L P (Filed by)
| Form SC 13G/A | |
02/13/2024 6:23 PM | Annexon (Subject) Logos Global Management LP (Filed by)
| Form SC 13G/A | |
02/13/2024 5:57 PM | Annexon (Subject) Bain Capital Life Sciences Fund, L.P. (Filed by)
| Form SC 13G/A | |
02/12/2024 2:39 PM | Annexon (Subject) Yednock Ted (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024 2:40 PM | Annexon (Subject) Lew Jennifer (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024 2:41 PM | Annexon (Subject) Love Douglas (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024 2:45 PM | Annexon (Subject) Overdorf Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/07/2024 6:02 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) Annexon (Subject)
| Form SC 13G/A | |
01/23/2024 3:57 PM | Annexon (Issuer) Lew Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2024 3:58 PM | Annexon (Issuer) Overdorf Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 7:53 AM | Annexon (Subject) FMR LLC (Filed by)
| Form SC 13G | |
12/29/2023 3:12 PM | Annexon (Issuer) Yednock Ted (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/28/2023 3:30 PM | Annexon (Issuer) Annexon (Issuer) Satter Muneer A (Reporting) Satter Muneer A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2023 3:50 PM | Annexon (Subject) Yednock Ted (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023 4:28 PM | Annexon (Filer)
| Form 8-K/A | |
12/20/2023 4:17 PM | Annexon (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/20/2023 4:24 PM | Annexon (Subject)
| Form FWP | |
10/24/2023 3:30 PM | Annexon (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/11/2023 3:44 PM | Annexon (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2023 7:36 AM | Annexon (Subject) FEDERATED HERMES, INC. (Filed by) FEDERATED HERMES, INC. (Filed by)
| Form SC 13G/A | |
07/13/2023 2:37 PM | Annexon (Subject) Lew Jennifer (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/13/2023 2:26 PM | Annexon (Subject) Overdorf Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/13/2023 2:31 PM | Annexon (Subject) Yednock Ted (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/22/2023 12:25 PM | Annexon (Subject) Logos Global Management LP (Filed by)
| Form SC 13G | |
He Is Giving Away Bitcoin (Ad) And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously.
Right now is a very important time to pay attention to what we are doing and what is happening.
If you wait... it will be too late.
This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here |
06/12/2023 4:52 PM | Annexon (Issuer) Satter Muneer A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2023 3:45 PM | Annexon (Issuer) Waddill William D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2023 3:48 PM | Annexon (Issuer) Cockroft Bettina M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2023 3:49 PM | Annexon (Issuer) Choi Jung (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2023 3:50 PM | Annexon (Issuer) WIGGANS THOMAS G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2023 8:54 PM | Annexon (Issuer) Bain Capital Life Sciences Fund, L.P. (Reporting) Bain Capital Life Sciences Investors, LLC (Reporting) Bain Capital Life Sciences Partners, LP (Reporting) BCIP Life Sciences Associates, LP (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2023 8:55 PM | Annexon (Issuer) Bain Capital Life Sciences Fund, L.P. (Reporting) Bain Capital Life Sciences Investors, LLC (Reporting) Bain Capital Life Sciences Partners, LP (Reporting) BCIP Life Sciences Associates, LP (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
05/25/2023 5:08 AM | Annexon (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |